Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Accumulated Expenses (2016 - 2026)

SANUWAVE Health has reported Accumulated Expenses over the past 17 years, most recently at $8.6 million for Q1 2026.

  • Quarterly Accumulated Expenses rose 21.04% to $8.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.6 million through Mar 2026, up 21.04% year-over-year, with the annual reading at $8.4 million for FY2025, N/A changed from the prior year.
  • Accumulated Expenses was $8.6 million for Q1 2026 at SANUWAVE Health, up from $8.4 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $8.6 million in Q1 2026 and troughed at $2.7 million in Q3 2023.
  • The 5-year median for Accumulated Expenses is $5.6 million (2023), against an average of $5.7 million.
  • The largest YoY upside for Accumulated Expenses was 2006.67% in 2022 against a maximum downside of 53.11% in 2022.
  • A 5-year view of Accumulated Expenses shows it stood at $4.1 million in 2022, then surged by 48.05% to $6.0 million in 2023, then dropped by 12.64% to $5.2 million in 2024, then soared by 59.93% to $8.4 million in 2025, then increased by 2.41% to $8.6 million in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Accumulated Expenses are $8.6 million (Q1 2026), $8.4 million (Q4 2025), and $7.9 million (Q3 2025).